Insurance when you live with an ongoing condition

One question is already answered

Whether an insurer will take on a condition you already have is decided at application, on the medical questionnaire, and the possible outcomes — acceptance, a surcharge, an exclusion, a deferral, a decline — belong to pre-existing conditions, which sets them out in full. That page owns the question and this one does not revisit it.

What follows here starts one step later, at the point where a condition is inside the policy and the years of ordinary use begin. That is a different test. A policy chosen well for someone who visits a doctor twice a year can behave quite differently for someone whose condition means eight or ten contacts across the same period — not because the cover is worse, but because every structure inside it that is priced per use is now being used.

Many people in this position end up using both systems rather than choosing between them — a public prescribing and monitoring route alongside private access for speed on the things that would otherwise wait. That is a normal arrangement rather than a sign that something has failed, and it works best when it is deliberate: one current medication list, one set of results, each side told what the other has done. The cost of running both carelessly is duplicated tests and a doctor making decisions on half a picture.

The arithmetic of frequency

Most policy structures are described per event: a copayment per consultation, per test, per session. Read one at a time they are small, and they are meant to be. Read against a year of a managed condition — the reviews, the blood tests, the imaging, the physiotherapy or dietetic or nursing input that goes with it — the same numbers are doing something else.

There is a simple exercise worth doing before buying, and it takes ten minutes. Write down the contacts you actually expect in a year: how many specialist reviews, how many tests, how many sessions of anything repeated. Then ask the insurer for the copayment applying to each of those items, and multiply. The result is the number that should be compared against the difference in premium between structures — and it is a number nobody can produce for you, because only you know how your year goes.

The general method for making that comparison, including what to do when the two structures are not otherwise identical, is in copayments and no-copayment policies. The point specific to an ongoing condition is only this: your usage is not a guess. You can count it, which most buyers cannot, and that makes the comparison unusually reliable for you.

Medication is where the systems part company

This is the gap that surprises people most often, because it is not intuitive from either direction.

The structural reason is worth understanding, because it predicts the answer better than any claim about the market would. A private policy pays for care delivered through its network — the consultation, the test, the admission, the medicine administered to you while you are in the bed. A prescription you take to a pharmacy afterwards is not delivered through that network at all; it is dispensed through the national pharmacy system, which has its own funding arrangement described below.

So the question to put to your insurer, in writing, is narrow and answerable: does this policy pay anything towards medication dispensed at a pharmacy, and if so under what heading? For a condition managed largely by medication, the answer can be the difference between a manageable year and the largest recurring health cost you have — so it is worth asking before you need it rather than discovering it at the counter.

The public system handles it differently. Spain operates a prescription co-payment in which residents usually pay between 10% and 60% of the cost of prescription medication, with the proportion depending on individual circumstances. It is worth knowing that the same arrangement extends to some other categories — orthopaedic services, prostheses, non-urgent transport and dietary supplies are among the things for which a percentage may be payable — because those are exactly the categories a long-term condition tends to reach.

That leaves you with something to do. Ask the insurer plainly what the policy does about medication you collect from a pharmacy, and treat any answer that is not in the conditions as marketing. And if you are entitled to public healthcare, the prescribing route is one place where using both systems deliberately is entirely ordinary rather than a failure of the private one. Prescriptions in Spain sets out how that works in practice, and who can access public healthcare whether the route is open to you.

Reviews, and the paperwork that repeats

A managed condition generates a rhythm: see the specialist, have the tests, review the results, adjust, repeat. Where a policy requires prior authorisation, that rhythm meets an administrative step, and the question worth settling early is which parts of your own cycle need it each time.

Ask specifically: does the follow-up consultation need authorising, or only the investigations? Is an authorisation valid for a course of something or for a single occurrence? Can the specialist’s office request it directly rather than sending you round the loop each time? The mechanics, the timescales and what to do when an authorisation is refused are in authorisations; what matters here is that a step which is a minor irritation once a year is a real feature of your life when it happens quarterly, and it is worth optimising once rather than repeatedly.

Continuity of clinician matters more than it does for episodic care, too. Ask how the policy handles seeing the same specialist over years rather than a network position generally — medical networks and hospitals covers how directories work and what changes when a practitioner leaves one.

Where the ceilings sit

Frequent use is also the way people meet limits that occasional users never see. Policies can carry an overall annual ceiling, and more commonly they carry sublimits: a maximum number of sessions of a therapy, a cap on a category of test, a ceiling on a particular benefit within an otherwise generous total.

For a condition managed with repeated input, a sublimit on the exact service you rely on is the number that decides whether the cover works for you, and it will not be the number in the advertisement. Ask which limits apply to the services your condition uses, what happens if a course of treatment is still running when one is reached, and on what date they reset. Annual limits explains how they are structured and where to find yours.

The renewal, which is the year’s real decision point

Spanish health cover is generally an annual contract that continues by tacit renewal unless someone opposes it. The law sets the notice: at least one month in advance from the policyholder, two months from the insurer, with the conditions and deadlines for that opposition required to be highlighted in the policy itself.

Practically, that means the renewal is a document to read rather than a payment to let through — and it is worth reading each year for what changed, what it now costs and whether the cover still has the shape you rely on. None of that requires any assumption about what an insurer will do:

What changed in the conditions. Benefits, sublimits and copayment schedules can be revised at renewal. A clause that reduces what you are entitled to is a limiting clause, and Spanish contract law requires those to be highlighted specially and accepted specifically in writing rather than absorbed quietly into a new document.

What the premium now is, and why. Renewal premium increases covers how the price moves and what can reasonably be asked about it.

Whether the services you actually use are still there in the same shape. For most policyholders the answer is a formality. For someone whose year depends on a particular sublimit, it is the whole point of reading.

If you consider moving

Switching insurer with a condition already covered is a different exercise from buying a first policy, and the order of operations is what protects you. A new insurer underwrites afresh, so what is covered on your current policy is not automatically what a new one would take on; and waiting periods can restart unless the new insurer agrees in writing to waive them on the strength of unbroken previous cover.

The sequence that avoids the worst outcome is simple and non-negotiable: get the new terms — including how your condition is treated and what happens to waiting periods — confirmed in writing before cancelling anything. Switching insurer sets out the steps, and continuous cover why the unbroken record is worth protecting.

Keep your own file

One habit does more for a long-term condition than any policy feature: hold your own records. Reports, discharge summaries, test results with their reference ranges, imaging, and a current medication list.

Care crosses systems — public and private, one specialist and the next, one insurer and another — and the record is what travels with you when nothing else does. It is what makes a new doctor useful on the first appointment rather than the third, and it is what turns a disputed claim into a documented one. Ask for a copy of everything as it is produced, rather than reconstructing it years later when it matters.